Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Urine Drug Testing with GC/MS Confirmation and Medical Review

Active
State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Mississippi → Human ResourcesView Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

MS, USA

Set-Aside

NONE

Documents

This scope was carved out of 2026-SOQ-209.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

MSDH Drug and Alcohol Testing Services for Employees

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyMississippi → Human Resources
ContactsNo contacts available
OfficeN/A
Organization / Agency
Mississippi → Human Resources
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform SAMHSA and HHS-certified urine drug screening, including specimen collection, GC/MS confirmation, and Medical Review Officer (MRO) review of non-negative results.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
Q301--Q&A CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICES CLOSE 08/21/2026 17:00
Solicitation # 36C24226Q0875
Solicitation 36C24226Q0875 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the Department of Veterans Affairs for the Northport VA Medical Center. The objective is to secure comprehensive, clinically validated molecular diagnostic testing using Next Generation Sequencing (NGS) to improve the management of thyroid nodules with indeterminate fine-needle aspiration (FNA) cytology. The contract covers a five-year performance period from October 1, 2026, to September 30, 2031, with a minimum quantity of 30 tests and a maximum of 600 tests. The scope includes cytopathology evaluation, reflex molecular testing, the provision of collection and shipping kits, and professional consultation. Award will be based on best-value, where technical capability and past performance are weighted more heavily than price. Key evaluation factors include diagnostic performance, molecular testing capabilities, quality management certifications such as CLIA and CAP, and the qualifications of key personnel, specifically board-certified molecular pathology oversight. While the solicitation is not set aside for small businesses, evaluation credit will be granted to Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB) verified in the VIP database. Quotes must be submitted electronically to Contract Specialist Mariangie Rivera by 5:00 PM EST on August 21, 2026.
242-NETWORK Contract Office 02 (36C242)

POSTED

2 days ago

DEADLINE

in 6 days
View Details

More opportunities from Mississippi → Human Resources

Same awarding agency